Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Cell Death & Disease|April 18, 2023
PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancerFengzhu Guo, Jialu Ma, Cong Li, et al.Nature Metabolism|October 31, 2023
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancyXuefeng Dou, Qiang Fu, Qilai Long, et al.Vaccine|November 28, 2023
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccineYuanyuan Wang, Yunqi Hu, Yong Ma, et al.Nature Protocols|February 2, 2024
Comprehensive multiscale analysis of lactate metabolic dynamics in vitro and in vivo using highly responsive biosensorsAoxue Wang, Yejun Zou, Shuning Liu, et al.Cellular & Molecular Immunology|October 11, 2022
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concernJingyi Yang, Mei-Qin Liu, Lin Liu, et al.Cell Reports|July 21, 2021
A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variantBali Zhao, Jingyi Yang, Bing He, et al.NPJ Vaccines|February 20, 2026
A modular three in one mucosal vaccine against three antigenic clusters of ACE2 using sarbecovirusesLin Liu, Haofeng Lin, Min Li, et al.Signal Transduction and Targeted Therapy|August 31, 2021
VAV2 is required for DNA repair and implicated in cancer radiotherapy resistanceWeiling Liu, Chuanwang Miao, Shaosen Zhang, et al.Emerging Microbes & Infections|March 27, 2026
A potent Gc neutralizing antibody reveals architecture-dependent bispecific protection against SFTSVHongjie Lu, Liushuai Li, Nan Zhang, et al.Signal Transduction and Targeted Therapy|April 27, 2024
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1Xian Li, Mengxin Xu, Jingyi Yang, et al.Pageof 8